Transient regulatory T-cells: A state attained by all activated human T-cells

Clinical Immunology

Volumn 123, Issue 1, 2007, Pages 18-29

  Pillai, Vinodh ^a   Ortega, Sterling B ^a   Wang, C K ^a   Karandikar, Nitin J ^a  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

CD4; CD8; FOXP3; Human; Regulatory T cells

Indexed keywords

ARTICLE; CELL ACTIVATION; CELL PROLIFERATION; DOWN REGULATION; EFFECTOR CELL; ENZYME ACTIVITY; HUMAN; HUMAN CELL; IMMUNE RESPONSE; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; REGULATORY T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION; THYMUS;

CELL LINEAGE; CELLS, CULTURED; FLOW CYTOMETRY; FORKHEAD TRANSCRIPTION FACTORS; HUMANS; LYMPHOCYTE ACTIVATION; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; T-LYMPHOCYTE SUBSETS; T-LYMPHOCYTES, REGULATORY;

EID: 33947121146     PISSN: 15216616     EISSN: 15217035     Source Type: Journal    
DOI: 10.1016/j.clim.2006.10.014     Document Type: Article

References (52)

1. Sakaguchi S. Naturally arising Foxp3-expressing CD25+CD4+ regulatory T cells in immunological tolerance to self and non-self. Nat. Immunol. 6 (2005) 345-352
2. Fehervari Z., and Sakaguchi S. CD4+ regulatory cells as a potential immunotherapy. Philos. Trans. R. Soc. London, Ser. B Biol. Sci. 360 (2005) 1647-1661
3. Fontenot J.D., Gavin M.A., and Rudensky A.Y. Foxp3 programs the development and function of CD4+CD25+ regulatory T cells. Nat. Immunol. 4 (2003) 330-336
4. Hori S., Nomura T., and Sakaguchi S. Control of regulatory T cell development by the transcription factor Foxp3. Science 299 (2003) 1057-1061
5. Fontenot J.D., Rasmussen J.P., Williams L.M., Dooley J.L., Farr A.G., and Rudensky A.Y. Regulatory T cell lineage specification by the forkhead transcription factor foxp3. Immunity 22 (2005) 329-341
6. Khattri R., Cox T., Yasayko S.A., and Ramsdell F. An essential role for Scurfin in CD4+CD25+ T regulatory cells. Nat. Immunol. 4 (2003) 337-342
7. Yagi H., Nomura T., Nakamura K., Yamazaki S., Kitawaki T., Hori S., Maeda M., Onodera M., Uchiyama T., Fujii S., and Sakaguchi S. Crucial role of FOXP3 in the development and function of human CD25+CD4+ regulatory T cells. Int. Immunol. 16 (2004) 1643-1656
8. Bettelli E., Dastrange M., and Oukka M. Foxp3 interacts with nuclear factor of activated T cells and NF-kappa B to repress cytokine gene expression and effector functions of T helper cells. Proc. Natl. Acad. Sci. U. S. A. 102 (2005) 5138-5143
9. Schubert L.A., Jeffery E., Zhang Y., Ramsdell F., and Ziegler S.F. Scurfin (FOXP3) acts as a repressor of transcription and regulates T cell activation. J. Biol. Chem. 276 (2001) 37672-37679
10. Walker M.R., Carson B.D., Nepom G.T., Ziegler S.F., and Buckner J.H. De novo generation of antigen-specific CD4+CD25+ regulatory T cells from human CD4+CD25- cells. Proc. Natl. Acad. Sci. U. S. A. 102 (2005) 4103-4108
11. Walker M.R., Kasprowicz D.J., Gersuk V.H., Benard A., Van Leghen M., Buckner J.H., and Ziegler S.F. Induction of FoxP3 and acquisition of T regulatory activity by stimulated human CD4+CD25- T cells. J. Clin. Invest. 112 (2003) 1437-1443
12. Chen W., Jin W., Hardegen N., Lei K.J., Li L., Marinos N., McGrady G., and Wahl S.M. Conversion of peripheral CD4+CD25- naive T cells to CD4+CD25+ regulatory T cells by TGF-beta induction of transcription factor Foxp3. J. Exp. Med. 198 (2003) 1875-1886
13. Kretschmer K., Apostolou I., Hawiger D., Khazaie K., Nussenzweig M.C., and von Boehmer H. Inducing and expanding regulatory T cell populations by foreign antigen. Nat. Immunol. 6 (2005) 1219-1227
14. Fehervari Z., and Sakaguchi S. CD4+ Tregs and immune control. J. Clin. Invest. 114 (2004) 1209-1217
15. Fontenot J.D., and Rudensky A.Y. A well adapted regulatory contrivance: regulatory T cell development and the forkhead family transcription factor Foxp3. Nat. Immunol. 6 (2005) 331-337
16. Shevach E.M. Regulatory/suppressor T cells in health and disease. Arthritis Rheum. 50 (2004) 2721-2724
17. Liu W., Putnam A.L., Xu-Yu Z., Szot G.L., Lee M.R., Zhu S., Gottlieb P.A., Kapranov P., Gingeras T.R., de St Groth B.F., Clayberger C., Soper D.M., Ziegler S.F., and Bluestone J.A. CD127 expression inversely correlates with FoxP3 and suppressive function of human CD4+ T reg cells. J. Exp. Med. 203 (2006) 1701-1711
18. Gavin M.A., Torgerson T.R., Houston E., Deroos P., Ho W.Y., Stray-Pedersen A., Ocheltree E.L., Greenberg P.D., Ochs H.D., and Rudensky A.Y. Single-cell analysis of normal and FOXP3-mutant human T cells: FOXP3 expression without regulatory T cell development. Proc. Natl. Acad. Sci. U. S. A. 103 (2006) 6659-6664
19. Lan R.Y., Cheng C., Lian Z.X., Tsuneyama K., Yang G.X., Moritoki Y., Chuang Y.H., Nakamura T., Saito S., Shimoda S., Tanaka A., Bowlus C.L., Takano Y., Ansari A.A., Coppel R.L., and Gershwin M.E. Liver-targeted and peripheral blood alterations of regulatory T cells in primary biliary cirrhosis. Hepatology 43 (2006) 729-737
20. Campanelli A.P., Roselino A.M., Cavassani K.A., Pereira M.S., Mortara R.A., Brodskyn C.I., Goncalves H.S., Belkaid Y., Barral-Netto M., Barral A., and Silva J.S. CD4+CD25+ T cells in skin lesions of patients with cutaneous leishmaniasis exhibit phenotypic and functional characteristics of natural regulatory T cells. J. Infect. Dis. 193 (2006) 1313-1322
21. Epple H.J., Loddenkemper C., Kunkel D., Troeger H., Maul J., Moos V., Berg E., Ullrich R., Schulzke J.D., Stein H., Duchmann R., Zeitz M., and Schneider T. Mucosal but not peripheral FOXP3+ regulatory T cells are highly increased in untreated HIV infection and normalize after suppressive HAART. Blood 108 (2006) 3072-3078
22. Cao D., Borjesson O., Larsson P., Rudin A., Gunnarsson I., Klareskog L., Malmstrom V., and Trollmo C. FOXP3 identifies regulatory CD25bright CD4+ T cells in rheumatic joints. Scand. J. Immunol. 63 (2006) 444-452
23. Xu D., Fu J., Jin L., Zhang H., Zhou C., Zou Z., Zhao J.M., Zhang B., Shi M., Ding X., Tang Z., Fu Y.X., and Wang F.S. Circulating and liver resident CD4+CD25+ regulatory T cells actively influence the antiviral immune response and disease progression in patients with hepatitis B. J. Immunol. 177 (2006) 739-747
24. Roncador G., Brown P.J., Maestre L., Hue S., Martinez-Torrecuadrada J.L., Ling K.L., Pratap S., Toms C., Fox B.C., Cerundolo V., Powrie F., and Banham A.H. Analysis of FOXP3 protein expression in human CD4+CD25+ regulatory T cells at the single-cell level. Eur. J. Immunol. 35 (2005) 1681-1691
25. Karandikar N.J., Crawford M.P., Yan X., Ratts R.B., Brenchley J.M., Ambrozak D.R., Lovett-Racke A.E., Frohman E.M., Stastny P., Douek D.C., Koup R.A., and Racke M.K. Glatiramer acetate (Copaxone) therapy induces CD8(+) T cell responses in patients with multiple sclerosis. J. Clin. Invest. 109 (2002) 641-649
26. Crawford M.P., Yan S.X., Ortega S.B., Mehta R.S., Hewitt R.E., Price D.A., Stastny P., Douek D.C., Koup R.A., Racke M.K., and Karandikar N.J. High prevalence of autoreactive neuroantigen-specific CD8+ T cells in multiple sclerosis revealed by novel flow cytometric assay. Blood 103 (2004) 4222-4231
27. Parks D.R., Roederer M., and Moore W.A. A new "Logicle" display method avoids deceptive effects of logarithmic scaling for low signals and compensated data. Cytometry, A 69 (2006) 541-551
28. Herzenberg L.A., Tung J., Moore W.A., Herzenberg L.A., and Parks D.R. Interpreting flow cytometry data: a guide for the perplexed. Nat. Immunol. 7 (2006) 681-685
29. Perfetto S.P., Chattopadhyay P.K., and Roederer M. Seventeen-colour flow cytometry: unravelling the immune system. Nat. Rev., Immunol. 4 (2004) 648-655
30. Allan S.E., Passerini L., Bacchetta R., Crellin N., Dai M., Orban P.C., Ziegler S.F., Roncarolo M.G., and Levings M.K. The role of 2 FOXP3 isoforms in the generation of human CD4+ Tregs. J. Clin. Invest. 115 (2005) 3276-3284
31. De Rosa S.C., Herzenberg L.A., Herzenberg L.A., and Roederer M. 11-color, 13-parameter flow cytometry: identification of human naive T cells by phenotype, function, and T-cell receptor diversity. Nat. Med. 7 (2001) 245-248
32. Ziegler S.F. FOXP3: of mice and men. Annu. Rev. Immunol. 24 (2006) 209-226
33. Seddiki N., Santner-Nanan B., Tangye S.G., Alexander S.I., Solomon M., Lee S., Nanan R., and de Saint Groth B.F. Persistence of naive CD45RA+ regulatory T cells in adult life. Blood 107 (2006) 2830-2838
34. Wei S., Kryczek I., and Zou W. Regulatory T cell compartmentalization and trafficking. Blood 108 (2006) 426-431
35. Valmori D., Merlo A., Souleimanian N.E., Hesdorffer C.S., and Ayyoub M. A peripheral circulating compartment of natural naive CD4 Tregs. J. Clin. Invest. 115 (2005) 1953-1962
36. Seddiki N., Santner-Nanan B., Martinson J., Zaunders J., Sasson S., Landay A., Solomon M., Selby W., Alexander S.I., Nanan R., Kelleher A., and de St Groth B.F. Expression of interleukin (IL)-2 and IL-7 receptors discriminates between human regulatory and activated T cells. J. Exp. Med. 203 (2006) 1693-1700
37. Morgan M.E., van Bilsen J.H., Bakker A.M., Heemskerk B., Schilham M.W., Hartgers F.C., Elferink B.G., van der Zanden L., de Vries R.R., Huizinga T.W., Ottenhoff T.H., and Toes R.E. Expression of FOXP3 mRNA is not confined to CD4+CD25+ T regulatory cells in humans. Hum. Immunol. 66 (2005) 13-20
38. Bisikirska B., Colgan J., Luban J., Bluestone J.A., and Herold K.C. TCR stimulation with modified anti-CD3 mAb expands CD8+ T cell population and induces CD8+CD25+ Tregs. J. Clin. Invest. 115 (2005) 2904-2913
39. Manavalan J.S., Kim-Schulze S., Scotto L., Naiyer A.J., Vlad G., Colombo P.C., Marboe C., Mancini D., Cortesini R., and Suciu-Foca N. Alloantigen specific CD8+CD28- FOXP3+ T suppressor cells induce ILT3+ ILT4+ tolerogenic endothelial cells, inhibiting alloreactivity. Int. Immunol. 16 (2004) 1055-1068
40. Mantel P.Y., Ouaked N., Ruckert B., Karagiannidis C., Welz R., Blaser K., and Schmidt-Weber C.B. Molecular mechanisms underlying FOXP3 induction in human T cells. J. Immunol. 176 (2006) 3593-3602
41. Boettler T., Spangenberg H.C., Neumann-Haefelin C., Panther E., Urbani S., Ferrari C., Blum H.E., von Weizsacker F., and Thimme R. T cells with a CD4+CD25+ regulatory phenotype suppress in vitro proliferation of virus-specific CD8+ T cells during chronic hepatitis C virus infection. J. Virol. 79 (2005) 7860-7867
42. Rushbrook S.M., Ward S.M., Unitt E., Vowler S.L., Lucas M., Klenerman P., and Alexander G.J. Regulatory T cells suppress in vitro proliferation of virus-specific CD8+ T cells during persistent hepatitis C virus infection. J. Virol. 79 (2005) 7852-7859
43. Kinter A.L., Hennessey M., Bell A., Kern S., Lin Y., Daucher M., Planta M., McGlaughlin M., Jackson R., Ziegler S.F., and Fauci A.S. CD25(+)CD4(+) regulatory T cells from the peripheral blood of asymptomatic HIV-infected individuals regulate CD4(+) and CD8(+) HIV-specific T cell immune responses in vitro and are associated with favorable clinical markers of disease status. J. Exp. Med. 200 (2004) 331-343
44. Andersson J., Boasso A., Nilsson J., Zhang R., Shire N.J., Lindback S., Shearer G.M., and Chougnet C.A. Cutting edge: the prevalence of regulatory T cells in lymphoid tissue is correlated with viral load in HIV-infected patients. J. Immunol. 174 (2005) 3143-3147
45. Can super-antibody drugs be tamed?. Nature 440 (2006) 855-856
46. Wadman M. London's disastrous drug trial has serious side effects for research. Nature 440 (2006) 388-389
47. Beyersdorf N., Hanke T., Kerkau T., and Hunig T. CD28 superagonists put a break on autoimmunity by preferentially activating CD4+CD25+ regulatory T cells. Autoimmun. Rev. 5 (2006) 40-45
48. Beyersdorf N., Gaupp S., Balbach K., Schmidt J., Toyka K.V., Lin C.H., Hanke T., Hunig T., Kerkau T., and Gold R. Selective targeting of regulatory T cells with CD28 superagonists allows effective therapy of experimental autoimmune encephalomyelitis. J. Exp. Med. 202 (2005) 445-455
49. Lin C.H., and Hunig T. Efficient expansion of regulatory T cells in vitro and in vivo with a CD28 superagonist. Eur. J. Immunol. 33 (2003) 626-638
50. Legrand N., Cupedo T., van Lent A.U., Ebeli M.J., Weijer K., Hanke T., and Spits H. Transient accumulation of human mature thymocytes and regulatory T cells with CD28 superagonist in "human immune system" Rag2(-/-)gammac(-/-) mice. Blood 108 (2006) 238-245
51. Sarantopoulos S., Lu L., and Cantor H. Qa-1 restriction of CD8+ suppressor T cells. J. Clin. Invest. 114 (2004) 1218-1221
52. Mallone R., Kochik S.A., Reijonen H., Carson B., Ziegler S.F., Kwok W.W., and Nepom G.T. Functional avidity directs T-cell fate in autoreactive CD4+ T cells. Blood 106 (2005) 2798-2805